CLINICAL_TRIALS trial_result · 2011-08-19

Clinical Trial Update: The Efficacy of Oral Everolimus in Patients With Neovascular Age-related Macular Degeneration [Phase 2]

Summary

Phase 2 study evaluating oral everolimus for neovascular age-related macular degeneration was terminated, with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Choroidal Neo-Vascular Age-onset Macular Degeneration, Age-related Macular Degeneration | Phase 2 | Status: TERMINATED | Results posted: 2011-08-19